Extracellular embryo genomic DNA and its potential for genotyping applications

BACKGROUND: Preimplantation genetic diagnosis (PGD) currently relies on biopsy of one or few embryo cells. Our aim was to evaluate the embryo extracellular matrices (spent medium and blastocoele fluid) as source of DNA for embryo genotyping. RESULTS/METHODOLOGY: We first evaluated the amplifiability...

Descripción completa

Detalles Bibliográficos
Autores principales: Galluzzi, Luca, Palini, Simone, Stefani, Silvia De, Andreoni, Francesca, Primiterra, Mariangela, Diotallevi, Aurora, Bulletti, Carlo, Magnani, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2015
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137924/
https://www.ncbi.nlm.nih.gov/pubmed/28031914
http://dx.doi.org/10.4155/fso.15.62
Descripción
Sumario:BACKGROUND: Preimplantation genetic diagnosis (PGD) currently relies on biopsy of one or few embryo cells. Our aim was to evaluate the embryo extracellular matrices (spent medium and blastocoele fluid) as source of DNA for embryo genotyping. RESULTS/METHODOLOGY: We first evaluated the amplifiability and the amount of genomic DNA in spent embryo culture media from day 3 (n = 32) and day 5/6 (n = 54). Secondly, we evaluated the possibility to genotype the MTHFR polymorphism C677T from media at day 5/6 (n = 8) and blastocoele fluids (n = 9) by direct sequencing. The C677T polymorphism detection rate was 62.5 and 44.4% in medium and fluid, respectively. CONCLUSION: A noninvasive approach for embryo genotyping was possible, but still with limitations due to low detection rate and possible allele dropout.

Ejemplares similares